As GLP-1 receptor agonists, these peptide drugs mimic the incretin hormone GLP-1, enhancing glucose-dependent insulin secretion, suppressing glucagon release, delaying gastric emptying, and reducing appetite [9]
Shifts in the functional capacity and metabolite composition of the gut microbiome during recovery from enteric infection
The ADDF is the only public charity solely focused on funding the development of drugs for Alzheimer's, employing a venture philanthropy model to support research in academia and the biotech industry
If you already have fibromyalgia-related fatigue, it can be hard to tell whats driving any new tiredness
"Sometimes we find as many as six impossible things before breakfast" jci.org/articles/view/ Thanks for sharing Does this "miracle" drug has any side effects
Drug products formed by combining anti-obesity agents is also promising